Moderna's CEO, Stephane Bancel, has expressed interest in establishing manufacturing sites in Germany, specifically targeting facilities slated for closure by its domestic competitor BioNTech.
Moderna, a leading US pharmaceutical firm (MRNA.O), is exploring investment opportunities in German production facilities, particularly those slated for closure by its German competitor BioNTech, according to CEO Stephane Bancel's remarks to Handelsblatt on Wednesday.
Related ↗Prince George set for esteemed education at Eton.Moderna's CEO considers partnering with Germany as a viable alternative to constructing new facilities, given the right collaboration with local authorities.
Moderna, a leading US pharmaceutical firm (MRNA.O),is exploring investment opportunities in German production facilities, particularly those slated for closure by its German competitor BioNTech, according to CEO Stephane Bancel's remarks to Handelsblatt on Wednesday.
Read next ↗Algae infestation prompts emergency response at Reflecting Pool.

